• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Nilotinib

Nilotinib

Product ID N3346
Cas No. 641571-10-0
Purity ≥99%
Product Unit SizeCostQuantityStock
10 mg $75.10 In stock
25 mg $165.40 In stock
100 mg $488.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Nilotinib is a second-generation phenylamino pyridine tyrosine kinase inhibitor that is clinically used to treat Bcr-Abl-positive chronic myelogenous leukemia (CML). Nilotinib is an ATP-competitive inhibitor of Abl, c-Kit, and PDGFR that exhibits anticancer chemotherapeutic, anti-fibrotic, anti-allergic, and anti-inflammatory activities. In cellular and animal models of hepatocellular carcinoma, nilotinib increases activation of AMPK and inhibits protein phosphatase 2A (PP2A), inducing autophagy in vitro and inhibiting tumor xenografts growth in vivo. In hepatic stellate cells, nilotinib decreases expression of histone deacetylases 1, 2, and 4 (HDAC1/2/4), increasing apoptotic cell death. In animal models of allergic reaction and inflammation, nilotinib inhibits expression of TNF-α and prevents mast cell histamine release, decreasing paw edema and preventing systemic anaphylaxis.

Product Info

Cas No.

641571-10-0

Purity

≥99%

Formula

C28H22F3N7O

Formula Wt.

529.52

Chemical Name

4-Methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide

IUPAC Name

4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4- pyridin-3-ylpyrimidin-2-yl)amino]benzamide

Synonym

AMN 107, Tasigna

Appearance

Yellowish to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

N3346 MSDS PDF

Info Sheet

N3346 Info Sheet PDF

References

Shaker ME, Ghani A, Shiha GE, et al. Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases. Biochim Biophys Acta. 2013 Aug;1833(8):1992-2003. PMID: 23499874.

Yu HC, Lin CS, Tai WT, et al. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J Biol Chem. 2013 Jun 21;288(25):18249-59. PMID: 23677989.

El-Agamy DS. Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions. Eur J Pharmacol. 2012 Apr 5;680(1-3):115-21. PMID: 22329898.

Fabbro D, Manley PW, Jahnke W, et al. Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site. Biochim Biophys Acta. 2010 Mar;1804(3):454-62. PMID: 20152788.

Quintás-Cardama A, Cortes J. Nilotinib: a phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases. Future Oncol. 2008 Oct;4(5):611-21. PMID: 18922118.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • U682040

    URB597

    FAAH inhibitor.

    ≥98%
  • K040009

    KB-0742 dihydrochloride

    CDK9 inhibitor.

    ≥99%
  • I7456

    1-Isothiocyanato-7-(methylsulfinyl)-heptane

    ITC, radical scavenger.

    ≥98%
  • T0298

    Tazobactam

    β-lactamase inhibitor.

    ≥98%
  • M5675

    Motilin, canine

    Endogenous peptide hormone; motilin agonist.

    ≥95%
  • A9708

    AZD-1208

    Pim-1 inhibitor.

    ≥98%
  • Z5744

    Zoledronic Acid Hydrate

    Bisphosphonate; FPPS inhibitor.

    ≥98%
  • B807214

    Buflomedil Hydrochloride

    Alpha blocker and vasoactive agent.

    ≥99%
  • B1746

    Belinostat

    HDAC inhibitor.

    ≥98%
  • P7033

    Primaquine Phosphate

    Alters membrane permeability, prevents transpor...

    ≥98% (titration)
  • G1408

    GDC-0449

    Smo inhibitor.

    ≥98%
  • H3278

    HIV Reverse Transcriptase A2.1 Peptide

    Peptide, HIV-1 RT A2.1 epitope.

    ≥95%
  • M578522

    Monascin

    Fungal pigment found in red yeast rice

    ≥98%
  • M704793

    MRTX1719

    PRMT5/MTA complex inhibitor

    ≥95%
  • B0396

    BAY80-6946

    p110α PI3K inhibitor.

    ≥98%
  • V0045

    Valacyclovir Hydrochloride

    Neuraminidase inhibitor.

    ≥98%
  • P6959

    Prothionamide

    Nicotinic acid derivative; InhA inhibitor.

    ≥98%
  • N1979

    Neuromedin

    Endogenous proneurotensin peptide, involved in ...

    ≥95%
  • V1668

    Vemurafenib

    B-Raf inhibitor.

    ≥98%
  • V3276

    Vitamin E, Natural

    Antioxidant.

    ≥97%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only